Published on

April 19, 2019

Last updated on

March 29, 2022

New Approval Process for Medical Device Clinical Trials

New Approval Process for Medical Device Clinical Trials

On 01.04.2019, the NMPA (National Medical Products Administration - former NMPA) announced a change in the clinical trial approval process for medical devices (NMPA No. 2019-26). If the applicant has not received any feedback within 60 working days from the date of clinical trial approval application, clinical trials can be carried out. Instead of an approval notification, the NMPA’s website will display the approval number, the applicant's name and address, as well as the name, the model specification, structure and composition of the medical device.

Connect with Cisema

With more than 20 years of experience and a team of over 100 specialists, Cisema helps global companies achieve compliance across Asia Pacific with confidence and accelerate market entry.

Talk to an Expert
Explore Whitepapers

Stay Informed with Monthly News and Analysis

Stay informed with the latest regulatory changes, expert insights, and market opportunities across APAC, delivered straight to your inbox.

Sign Up for Newsletter

Contact Our Consultants & Discover How We Can Support You

Let Cisema help turn your plans into reality.

Request Proposal